Navigation Links
Pittsburgh Based ParentPlus Enters Collaboration with Vitrolife
Date:11/21/2011

PITTSBURGH, Nov. 21, 2011 /PRNewswire/ -- ParentPlus LLC, a Pittsburgh based product development company specializing in commercializing innovative and proprietary human fertility technologies, is entering into a license agreement with Vitrolife AB Sweden, with the aim of further development of new products for IUI (Intra-Uterine Insemination, artificial insemination).

"I am proud and pleased to announce the signing of this agreement which is a notable milestone on our way to realize our vision to give millions of couples accessible, less complicated and less costly fertility options with a higher rate of success," said Karl Forssman, President and CEO of ParentPlus LLC. "We look forward to the opportunity to help these couples turn their dream of holding a newborn into reality."

Mr. Forssman continued, "The very number of IUI treatments currently being performed constitutes a great commercialization opportunity. Our partner, Vitrolife, is currently committed to improving every step during the in vitro fertilization (IVF). By combining our research and testing strengths within IUI with Vitrolife's proven support of IVF treatments world wide, we see opportunities to increase the value of IUI within assisted fertilization through more effective treatment." Mr. Forssman concluded, "ParentPlus's research and testing around our IUI product has been long and extensive. With this collaboration and a clear roadmap ahead, our next step as a growing organization is to be able to raise capital for product development and integration of other related products."

About Intra-Uterine Insemination, artificial insemination (IUI)

In many countries IUI treatment is a requirement before IVF (In Vitro Fertilization) treatment can begin. It is estimated that there is a market for between 4-6 million treatments a year, with a market value around USD 150-300 million. IUI, "artificial insemination," is a process where the sperm are prepared by separating them from the seminal fluid and then injecting them so that a high concentration of active and motile sperm are introduced directly through the cervix into the uterus and the fallopian tubes, where fertilization of the egg takes place. The method is simple and cost-effective and more or less doubles the chances of getting pregnant compared with intercourse during the estimated ovulation period, but it has limitations concerning which groups for which the treatment works.

About ParentPlus LLC

ParentPlus was formed to commercialize innovative and proprietary human fertility technologies. The Company will, in its first stage, manufacture and sell biotechnology applications to alleviate male subfertility. The Company's goal is to provide the more than 75 million subfertile couples worldwide, currently trying to achieve pregnancy, better odds of fulfilling their dreams of having children. The Company's initial product will increase the efficacy of fertility treatments and at the same time provide a lower cost alternative to expensive and highly publicized conventional treatments.

About Vitrolife

Vitrolife is a global biotechnology/medical device Group that works with developing, manufacturing and selling advanced products and systems for the preparation, cultivation and storage of human cells, tissue and organs.  The company has business activities within three product areas: Fertility, Transplantation and Stem Cell Cultivation. Vitrolife today has approximately 220 employees and its products are sold in more than 90 markets. The company is headquartered in Gothenburg, Sweden, and there are subsidiaries in USA, Australia, France, Italy, United Kingdom and Japan. Production facilities are located in Sweden and the USA. The Vitrolife share is listed on NASDAQ OMX Stockholm, Small Cap. www.vitrolife.com.


'/>"/>
SOURCE Pittsburgh Life Sciences Greenhouse
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Childrens Hospital of Pittsburgh of UPMC Receives Prestigious Recognition for Patient Safety Efforts in National Survey
2. Pittsburgh Technology Council Announces Technology 50
3. Opening Dedication of the New John G. Rangos Sr. Research Center at the New Childrens Hospital of Pittsburgh of UPMC Campus in Lawrenceville
4. NIH Awards Approximately $3M Grant for Research Involving WaferGens SmartChip(TM) Real-Time PCR System at the University of Pittsburgh
5. Delcath Adds University of Pittsburgh Medical Center to Phase III Trial
6. The Pittsburgh Life Sciences Greenhouse Starts 2009 With Investment Momentum
7. Pittsburgh Life Sciences Greenhouse Demonstrates a Regions Economic Resilience
8. The Pittsburgh Life Sciences Greenhouse Adds Life Sciences Veterans to Executive Program
9. The Pittsburgh Life Sciences Greenhouse Invests $725K in Portfolio Companies
10. The Pittsburgh Life Sciences Greenhouse Announces Additions to Nationally Recognized Executive Program
11. Precision Therapeutics President and CEO Sean McDonald Recognized as Pittsburgh Technology Council Tech 50 CEO of the Year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2017)... ... September 22, 2017 , ... ... Justin Zalewsky in offering LANAP® and LAPIP™ laser treatments. Drs. Hoge and Zalewsky ... to patients, a minimally invasive and less painful option that produces real results. ...
(Date:9/21/2017)... ... September 21, 2017 , ... ... which includes executive, engineering and manufacturing functions to The LaunchPort™ Accelerator at the ... provide a full range of manufacturing and business services to its Residents. ...
(Date:9/21/2017)... (PRWEB) , ... September 21, 2017 , ... ... clinical client portal. Each relaunch of the portal includes new features that facilitate ... medical device companies seek to remain at the forefront of medical advancements, they ...
(Date:9/21/2017)... ... September 21, 2017 , ... When a downtown Greenville ... was swift and efficient thanks to the continuing efforts of members of the ... more than 50 stakeholders, including officials from area counties and cities, Renewable Water ...
Breaking Biology Technology:
(Date:4/13/2017)... According to a new market research report "Consumer IAM Market by Solution ... Authentication Type, Deployment Mode, Vertical, and Region - Global Forecast to 2022", ... 14.30 Billion in 2017 to USD 31.75 Billion by 2022, at a ... ... MarketsandMarkets Logo ...
(Date:4/11/2017)... N.Y. , April 11, 2017 ... fingerprints, but researchers at the New York University ... College of Engineering have found that partial similarities ... security systems used in mobile phones and other ... thought. The vulnerability lies in the ...
(Date:4/5/2017)... April 5, 2017  The Allen Institute for Cell ... Explorer: a one-of-a-kind portal and dynamic digital window into ... data, the first application of deep learning to create ... cell lines and a growing suite of powerful tools. ... these and future publicly available resources created and shared ...
Breaking Biology News(10 mins):